Search
Menu
Perkins Precision Developments - Plate Polarizers LB 4/24

Novozymes Biopharma AB

Facebook X LinkedIn Email
Novozymes Biopharma AB of Lund, Sweden, and Upperton Ltd. of Nottingham, UK, have been granted a European patent for their targeted drug delivery technology. The patent describes methods of conjugating antibodies and other targeting agents to protein carriers by using a heterobifunctional linker, making it possible to deliver large quantities of drugs to selected sites in the body.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: April 2009
    Biophotonicsheterobifunctional linkerNews & FeaturesNovozymes Biopharma ABUpperton Ltd

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.